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ABSTRACT
Zinc-finger nucleases and TALE nucleases are pro-
duced by combining a specific DNA-binding module
and a non-specific DNA-cleavage module, resulting
in nucleases able to cleave DNA at a unique se-
quence. Here a new approach for creating highly
specific nucleases was pursued by fusing a catalyt-
ically inactive variant of the homing endonuclease
I-SceI, as DNA binding-module, to the type IIP re-
striction enzyme PvuII, as cleavage module. The
fusion enzymes were designed to recognize a com-
posite site comprising the recognition site of PvuII
flanked by the recognition site of I-SceI. In order to
reduce activity on PvuII sites lacking the flanking
I-SceI sites, the enzymes were optimized so that
the binding of I-SceI to its sites positions PvuII for
cleavage of the composite site. This was achieved
by optimization of the linker and by introducing
amino acid substitutions in PvuII which decrease
its activity or disturb its dimer interface. The most
specific variant showed a more than 1000-fold pref-
erence for the addressed composite site over an
unaddressed PvuII site. These results indicate that
using a specific restriction enzyme, such as PvuII,
as cleavage module, offers an alternative to the
otherwise often used catalytic domain of FokI,
which by itself does not contribute to the specificity
of the engineered nuclease.
INTRODUCTION
Gene targeting allows the introduction of genetic elements
into chosen genomic loci. The usual approach to achieve
this goal is based on homologous recombination, the nat-
ural efﬁciency of which is quite low but can be stimulated
by double-strand breaks using engineered nucleases. For
gene targeting these endonucleases should recognize
unique sequences and cleave DNA highly speciﬁcally, and
thereby initiate double-strand break repair by induced
homologous recombination with a DNA template supplied
in trans (1,2).
Such nucleases with very high speciﬁcity have been en-
gineered by rational and combinatorial strategies (3):
among them are (i) zinc-ﬁnger nucleases (4–9), (ii) engin-
eered homing endonucleases (10–13) and (iii) triple helix
forming oligonucleotides linked to restriction enzymes
(14) or other DNA cleavage moduls (15,16).
Combining a cleavage module with a recognition mod-
ule in order to generate nucleases with high speciﬁcity was
ﬁrst achieved with the non-speciﬁc DNA cleavage domain
of the restriction endonuclease FokI and the Ubx
homeodomain (17), which was soon followed by the fusion
of zinc ﬁnger motifs to the FokI cleavage domain (18).
Most chimeric nucleases produced so far use the FokI
cleavage domain as cleavage module (19), and the majority
of them are zinc-ﬁnger nucleases. A noteworthy exception
is the fusion product consisting of a catalytically inactive
homing endonuclease and the FokI cleavage domain (20),
which resulted in a fusion protein recognizing the homing
endonuclease recognition site and cleaving the DNA in
both strands 2 and 6nt downstream from the recognition
site, as expected for the Type IIS restriction endonucleases
FokI. With a similar approach the
5mCpG-binding
domain of a
5mCpG-speciﬁc DNA glycosylase was fused
to the FokI cleavage domain, in order to obtain a chimeric
nuclease that cleaves DNA at
5mCpG-sites (21). Similarly,
the control protein C.BcII that represses the expression of
the methyltransferase of the BcII R-M system was fused to
the non-speciﬁc cleavage domain of BmrI; the chimeric
nuclease recognizes speciﬁc sites in the vicinity of the
C.BcII control sequence (22).
Recently, so called transcription activator like effector
(TALE) nucleases (TALENs) were produced; they consist
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cleavage domain as cleavage module. Similarly as
zinc-ﬁngers, TALEs can be designed to recognize different
DNA sequences (23,24) and therefore promise to be useful
for the production of engineered nucleases of extended
speciﬁcity (27–33).
To our knowledge no attempts have been made so far to
produce chimeric nucleases consisting of a homing endo-
nuclease (as a DNA-binding module) and a restriction
enzyme (as a DNA binding and cleavage module, respect-
ively). Such chimeric nucleases ideally should have an
extended speciﬁcity and should recognize a bipartite or
tripartite (in case of homodimeric restriction endonucle-
ases, see Figure 1A) recognition site, comprising that of
the homing endonuclease and that of the restriction endo-
nuclease and cleave the DNA within the recognition site of
the restriction endonuclease.
Type II restriction endonucleases are highly speciﬁc en-
zymes; they recognize DNA sequences of 4–8bp in length,
which means that their recognition sites will occur on
average every 4
4–4
8bp. PvuII (34), a homodimeric Type
IIP restriction endonuclease, for example, recognizes the
palindromic double-stranded DNA sequence CAG#CTG
and cleaves it in the presence of Mg
2+ as indicated,
generating blunt ends. Homing endonucleases are even
more speciﬁc, as they recognize much longer sequences
than restriction endonucleases (35). I-SceI (36,37), a
monomeric homing endonuclease of the LAGLIDADG
family, for example, recognizes an 18bp sequence (TAG
GGATAACAGGGTAAT) and in the presence of Mg
2+
cleaves the DNA within this sequence. Typically, homing
endonucleases cleave complex genomes at a few sites only.
A fusion protein consisting of PvuII as cleavage module
and a catalytically inactive I-SceI variant (= S*) as
binding module, separated by a linker Lx, for example
PLxS*, which upon dimerization (viz. S*LxP/PLxS*)
could be expected to recognize a 42bp sequence. This
composite site consists of one I-SceI site, one PvuII site
and one reverse complement of the I-SceI site: TAGGGA
TAACAGGGTAAT — CAG#CTG— ATTACCCTGTT
ATCCCTA. Cleavage should occur in the addressed PvuII
site at the position indicated. This requires that the cata-
lytic module, i.e. the PvuII part of the fusion protein is
only activated after the DNA binding modules, the two
I-SceI*parts of the fusion protein, have positioned the
catalytic module vis-a ` -vis the scissile phosphodiester
bonds of the PvuII site. The PLxS* fusion protein
should not be able to cleave an unaddressed PvuII site,
i.e. a PvuII site not ﬂanked by I-SceI sites. We demon-
strate here that by an appropriate choice of the linker
between PvuII and I-SceI* and by introducing amino
acid substitutions into PvuII and I-SceI*, the PLxS*
fusion protein cleaves with high preference addressed
PvuII sites.
Figure 1. (A) Cartoon representation of the fusion enzyme. The C-terminus of one subunit of a dimeric restriction enzyme (PvuII; blue) is fused via
a peptide linker (gray) to the N-terminus of a catalytically inactive homing endonuclease (I-SceI; green). This fusion enzyme binds as a homodimer to
a tripartite recognition site consisting of the PvuII recognition site (orange) ﬂanked by two I-SceI sites (red) separated by an un-speciﬁed DNA
(gray). The very C-terminal Strep-tag used for afﬁnity puriﬁcation is depicted in yellow. (B) Model of the engineered fusion enzyme. One subunit of
the fusion enzyme consists of one I-SceI [green; pdb 1r7m (40)] and one subunit of the PvuII dimer [blue, pdb 1pvi (47)]. This model was built by
aligning the recognition sites from the crystal structures of the individual proteins on a DNA composed of the PvuII recognition site (orange) and
two I-SceI sites (red) separated by 6bp up- and downstream. The C-terminus of PvuII and the N-terminus of I-SceI, separated by 2.6nm, are
indicated by red spheres; this distance must be covered by a peptide linker of suitable length.
848 Nucleic Acids Research, 2012,Vol. 40,No. 2MATERIALS AND METHODS
Construction of the PvuII-I-SceI fusions
The PvuII-I-SceI fusion enzyme and variants thereof were
created by fusing scPvuII (38) or wt PvuII (39) via their
C-terminus to the N-terminus of a catalytically inactive
variant of I-SceI (I-SceI*) which had been truncated at
the C-terminus ( C9). These last nine amino acid
residues were not resolved in the co-crystal structure of
I-SceI (40). For this construction, the genes coding for
scPvuII or wt PvuII with the coding sequence for a
C-terminal His6-tag were connected to the gene coding
for I-SceI(D44S) (41) and introduced into the vector
pASK-IBA63b-plus (IBA) coding for a C-terminal
Strep-tag. For further improvement of the fusion protein
two active site residues of I-SceI were exchanged (D44N
and D145A) according to (20) via PCR-based site-directed
mutagenesis (42). The mutagenesis of selected residues of
PvuII was performed in the same way for the fusion
protein and for PvuII alone (for control reasons), whose
gene was also introduced into pASK-IBA63b-plus.
Between the genes for PvuII and I-SceI three restriction
enzyme sites (NheI, BsiWI, AgeI) were introduced,
replacing the coding sequence for the His6-tag (LH !
L6, where L denotes the linker). By cleaving the resulting
vector with NheI and AgeI, and ﬁlling in, the linkers LN,
L+ and L - were obtained. The correctness of all genetic
constructs was conﬁrmed by sequencing over the entire
coding region for PvuII-Lx-I-SceI, containing the different
linkers Lx (LH, L6, LN,L + and L ).
Puriﬁcation of the enzymes
The pASK-IBA63b-plus plasmids harboring the coding se-
quences for the fusion enzymes or PvuII alone were
introduced into Escherichia coli strain XL-Gold, which
had been transformed before with a plasmid encoding
the PvuII methyltransferase gene (pLGM). The cells
were grown at 37 Ct oa nO D 600 of 1. Protein expression
was induced by adding 200mg/l anhydrotetracycline,
followed by further growth at 20 C overnight. After har-
vesting the cells by centrifugation the cell pellet was
dissolved in 100mM Tris–HCl, pH 8, 1M NaCl, 1mM
EDTA, lysed by soniﬁcation and centrifuged for 30min
(>17000g) to remove cell debris. The recombinant Strep-
tagged proteins were puriﬁed using Strep-Tactin Sepharose
(IBA). After washing with a high-salt (100mM Tris–HCl,
pH 8, 1M NaCl, 1mM EDTA) and a low-salt (100mM
Tris–HCl, pH 8, 300mM NaCl, 1mM EDTA) washing
buffer, the tagged proteins were eluted with 100mM
Tris–HCl, pH 8.0, 300mM NaCl, 2.5mM desthiobiotin.
The purity of the eluates was analyzed by SDS-PAGE and
selected fractions were pooled and dialysed overnight
(50mM Na-phosphate, pH 7.5, 100mM NaCl, 0.5mM
EDTA, 60% glycerol). Protein concentration was
determined by A280 measurements using a molar extinc-
tion coefﬁcient of 92250M
 1cm
 1 at 280nm as calculated
from the amino acid composition (43). Protein concentra-
tions are given as dimers throughout the text.
DNA cleavage assays
DNA cleavage activity assays were carried out with 50nM
of a 454bp PCR fragment containing one I-SceI site.
This substrate was incubated with either 5U I-SceI
(Fermentas) in Buffer Tango (Fermentas), 100nM PvuII
or 100nM scPLHS* in Buffer Green (Fermentas) for
45min at 37 C. Cleavage products were separated by
6% PAGE, stained with ethidium bromide and visualized
by a BioDocAnalyze system (Biometra). The cleavage
products obtained with scPLHS* were gel puriﬁed and
sequenced.
For plasmid cleavage assays, the different target se-
quences (Table 2) were introduced into pAT153. The
plasmid substrate was used in 8nM concentration and
incubated with 8nM of the corresponding enzyme either
for 3h or overnight at 37 C. DNA cleavage by PvuII was
performed in Buffer Green (Fermentas), by the fusion en-
zymes in an optimized potassium glutamate buffer [KGB
(44)] (100mM K-glutamate, 25mM Tris–acetate, pH 7.5,
100mM KCl, 0.8mM Mg-acetate, 10mg/ml BSA, 0.5mM
2-mercaptoethanol). The cleavage products were separated
on 0.8% agarose gels, stained with ethidium bromide and
visualized by the BioDocAnalyze system. Quantiﬁcation
of linear product formation was performed by
densitometry.
For bacteriophage  -DNA (which contains 15 PvuII
sites) cleavage, the DNA concentration was chosen such,
that 8nM of PvuII sites (corresponding to 564pM
 -DNA) were incubated with 8nM fusion enzymes or
PvuII in optimized KGB or Buffer Green, respectively,
for 3h at 37 C.
Analytical ultracentrifugation
Protein PL6S* was puriﬁed as described above followed by
size exclusion chromatography on a Superdex 200 10/300
GL column with 50mM Na-phosphate, pH 7.5, 500mM
NaCl, 0.5mM EDTA. Fractions containing pure enzyme
were pooled and one-half was dialyzed against 50mM
Na-phosphate, pH 7.5, 500mM NaCl, 0.47M glycerol
(high salt conditions), the other half against 50mM Na-
phosphate, pH 7.5, 100mM NaCl, 0.47M glycerol (low
salt conditions).
Sedimentation velocity runs were performed at 5 C and
45000r.p.m. in a Beckman Coulter Optima XL-I using
the absorbance optics of the analytical ultracentrifuge.
The experiments were carried out in an An-50 Ti rotor
using 12mm standard double sector centerpieces ﬁlled
with 400ml sample. Under high-salt conditions protein
concentrations between 0.2 and 3.25mM were examined,
under low salt conditions a concentration of 1.75mM
was used. Depending on protein concentration, UV-
absorption was measured at 230 or 280nm, respectively.
Sedimentation proﬁles were analyzed using the program
SEDFIT (45), providing a model of diffusion-corrected
differential sedimentation coefﬁcient distributions [c(s)
distributions]. Partial speciﬁc volumes, buffer densities
and viscosities were determined with the program
SEDNTERP (46) and used to correct the sedimentation
coefﬁcients to s20,w.
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To test the speciﬁcity of the fusion enzymes for the ad-
dressed site, radioactively labeled PCR-fragments using
[a
32P] dATP containing either the addressed site (S6P6S,
for deﬁnition see Table 2) or the unaddressed site (P)
were produced. 10nM of each of these fragments were
incubated together with 10nM of the fusion enzymes in
KGB (100mM K-glutamate, 25mM Tris–acetate, pH
7.5, 100mM KCl, 0.8mM Mg-acetate, 10mg/ml BSA,
0.5mM 2-mercaptoethanol) at 37 C; after deﬁned
time intervals samples were taken and subjected to
polyacrylamide gel electrophoresis. Cleavage products
were analyzed with the Instant Imager system
(Packard) and quantiﬁed with the Instant Imager
software. Initial rates were calculated by linear regres-
sion analysis.
Electrophoretic mobility shift assay
The afﬁnity of the fusion enzymes to their target se-
quences was determined with electrophoretic mobility
shift assays (EMSAs), using radioactively labeled
DNA-fragments which were produced via PCR using
[a
32P] dATP. One fragment contained the addressed
site (S6P6S) and another one only an I-SceI site (S). For
KD determination 2nM of the radioactively labeled ad-
dressed substrate were incubated with fusion enzyme
in concentrations ranging from 1–150nM in KGB
without Mg
2+ for 30min at room temperature. For
the unaddressed substrate the enzyme concentration
ranged from 20 to 180nM. After adding 1ml 87%
glycerol the samples were loaded onto a 6% polyacryl-
amide Tris–acetate, pH 8.5 gel and subjected to electro-
phoresis for 2h at 10V/cm. The bands were visualized
using the Instant Imager system (Packard). The intensities
of bands representing free and bound DNA were
quantiﬁed with the Instant Imager software and the per-
centage of bound DNA was calculated. The data were ﬁt
and the KD determined using a non-linear regression
analysis.
RESULTS
Design of the fusion enzyme
For creating a highly speciﬁc nuclease with extended spe-
ciﬁcity the type IIP restriction endonuclease PvuII was
fused as the cleavage module to a catalytically inactive
variant of the homing endonuclease I-SceI (= S*) as an
additional binding module (Figure 1A). Due to the C2
symmetry of the homodimeric PvuII (= P) the fusion
would result in a protein with the PvuII homodimer
ﬂanked by two I-SceI* molecules. The fusion protein,
PLxS*, after homodimerization, should recognize a
sequence consisting of the PvuII recognition sequence
ﬂanked by two I-SceI recognition sequences, S...P...S
(where S and P denote the I-SceI and PvuII recognition
sequences, respectively).
In the co-crystal structure, the N-terminal part of
I-SceI is an a-helix sticking out of the otherwise
compact structure of this enzyme and could serve as an
attachment point for PvuII, as shown in a model of the
fusion protein in complex with DNA, which was
generated using the pdb coordinates for I-SceI
[pdb:1r7m (40)] and PvuII [pdb: 1pvi (47)] and ideal
B-DNA (Figure 1B). In this model the target sites for
I-SceI and PvuII are separated by 6bp, which leads to all
three proteins in the fusion protein approaching the
DNA from the same side.
Engineering of PvuII-I-SceI fusion enzymes and ﬁnding a
target with an optimum distance between the I-SceI and
the PvuII recognition site
In our ﬁrst construct, produced for the purpose of testing
our approach, the single chain variant of PvuII, scPvuII,
was fused via its C-terminal His6-tag as a linker (LH)t o
the catalytically inactive I-SceI D44S variant (41). The
DNA cleavage activity of the scPvuII-LH-I-SceID44S
fusion protein was tested on an oligonucleotide substrate
containing only an I-SceI site and no PvuII site, which we
expected not to be cleaved. However, a speciﬁc cleavage
pattern was obtained (Figure 2A), which after sequencing
of the product (Figure 2B) turned out to be due to
Figure 2. (A) Cleavage of 50nM of a 454bp PCR fragment containing an I-SceI recognition site. Lane 1 (-): uncleaved DNA fragment; Lane 2:
cleavage products obtained by incubation of the 454bp PCR fragment with 5 U I-SceI (Fermentas) in Buffer Tango; Lanes 3 and 4: cleavage
products obtained by incubation of the 454bp PCR fragment with 100nM PvuII and 100nM scPLHS, respectively, in Buffer Green. (B) Sequencing
results of the cleavage product of scPLHS* from (A). The fragments were gelpuriﬁed and sequenced in forward (upper panel) and reverse (lower
panel) direction. The I-SceI recognition sequence is indicated by a red bar and the cleavage site, which corresponds to a PvuII ‘star’ site by an orange
bar. These two sites are separated by 6bp.
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stream from the I-SceI site. ‘Star’ sites, which differ in one
base pair from the canonical recognition site, are only
attacked by type II restriction enzymes at high concentra-
tions of organic solvents such as DMSO and glycerol, at
alkaline pH or in the presence of Mn
2+. The DNA
cleavage result that we obtained, therefore, showed that
(i) I-SceI activates PvuII to cleave a site that it normally
would not attack and that it directs PvuII to this site, and
(ii) that a distance of 6bp between the I-SceI and the PvuII
recognition site in the substrate as predicted by the struc-
tural model (Figure 1B) is acceptable for the scPvuII-I-
SceI D44S fusion protein. The DNA cleavage activity of
this fusion protein was tested under various buffer condi-
tions, among them the KGB (100mM K-glutamate,
25mM Tris–acetate, pH 7.5, 10mM Mg-acetate, 10mg/
ml BSA, 0.5mM 2-mercaptoethanol) which had been de-
veloped to mimic physiological conditions (44) and to
which we added 100mM KCl and in which the concentra-
tion of Mg-acetate was decreased to 0.8mM, in order to
more closely approach the KCl and Mg
2+ concentration
prevailing in vivo. In this buffer the largest difference in
activity between scPvuII and scPLH S* (Supplementary
Figure S1) was observed, which means that the fusion
construct cleaves an addressed site much better than
scPvuII alone does. All further cleavage experiments of
the fusion enzymes were performed in the optimized
version of KGB (100mM K-glutamate, 25mM Tris–
acetate, pH 7.5, 100mM KCl, 0.8mM Mg-acetate,
10mg/ml BSA, 0.5mM 2-mercaptoethanol).
For all other constructs the homodimer of PvuII was
used instead of the single chain variant, which means that
the fusion proteins contains two I-SceI* binding modules
rather than one as in the scPvuII fusion proteins. The two
I-SceI* modules are linked via their N-termini to the
C-termini of the two PvuII subunits. For this construct,
we also used another I-SceI variant, namely
I-SceI C9,D44N,D145A; this variant has amino acid sub-
stitutions in both catalytic centers and is C-terminally
truncated. For the amino acid substitutions in the catalytic
center it was shown before, that this combination
improves the solubility of I-SceI (20). Since fusion proteins
with wtPvuII are homodimeric, their recognition site will
be longer and they are likely to be more speciﬁc. wtPvuII
and the I-SceI C9,D44N,D145A were fused using differ-
ent linkers (LH, L6, LN,L + and L ) (Table 1) which all
could cover the  26A ˚ distance between the C-terminus of
PvuII and the N-terminus of I-SceI in our structural model
(Figure 1B). These fusion proteins were expressed and
puriﬁed. To test these enzymes, substrates with different
distances between the I-SceI and the PvuII recognition
sites (Table 2) were produced. Considering the structural
model and the DNA cleavage results with scPL(H)S*
cleaving 6bp downstream from the I-SceI site, we tested
the different linker variants for speciﬁcity on the linearized
plasmid substrate S6P6S_P, i.e. a substrate containing a
PvuII site (P) ﬂanked by two I-SceI sites (S) in a 6bp
distance (6P and P6, respectively) and an additional single
PvuII site (_P) (Figure 3B). wtPvuII cleaves this substrate
at both PvuII sites (the addressed one, which is ﬂanked by
I-SceI sites, and the other one, which is unaddressed) re-
sulting in three major products, which shows, that PvuII
by itself has no preference for one of the sites due to
sequence context. The fusion enzymes in contrast cleave
preferentially the addressed site (S6P6S) resulting in the
fragments indicated with an arrow in Figure 3B. The un-
addressed site (_P) is also cleaved but much more slowly;
PL6S* and PL+S* cleaved the unaddressed site with an at
least two orders of magnitude slower rate than the ad-
dressed site (Table 4). Still, a plasmid substrate with
only an unaddressed PvuII site (Figure 3A) which is
quickly cleaved by wtPvuII is also cleaved by the fusion
enzymes, albeit with a lower rate. PL6S* and PL+S* show
the slowest unaddressed cleavage rate. For this reason
these variants were used for further optimization and
characterization.
Oligomeric state of PL6S*
PvuII is a homodimer in solution (48). In order to inves-
tigate if the fusion with I-SceI has an effect on the
oligomeric state, sedimentation velocity runs in the ana-
lytical ultracentrifuge were carried out. These experiments
were done at high and low salt conditions. Under high
salt conditions PL6S* sediments as a single species with
a sedimentation coefﬁcient of s20,w=4.4 S (Figure 4).
Increasing the protein concentration from 0.2 to 3.25mM
had no effect on the sedimentation coefﬁcient (data not
shown), indicating that PL6S* does not change its oligo-
merization state in this concentration range. Analysis of
the diffusion broadening of the sedimenting boundary
using the c(s) analysis in the program SEDFIT (45)
yielded a molar mass of about 83kg/mol. Since the
molar mass of the monomer as calculated from amino
acid composition is 46.7kg/mol, the protein most probably
is a homodimer. From the sedimentation analysis it can be
Table 2. Overview of the substrates used
Name Recognition sites
S I-SceI: TAATGGGACAATAGGGAT
P PvuII: CAGCTG
S4P4S I-SceI-4bp-PvuII-4bp-I-SceI
S6x6S I-SceI-6bp-KpnI-6bp-I-SceI
S6P6S I-SceI-6bp-PvuII-6bp-I-SceI
S6P6S_P I-SceI-6bp-PvuII-6bp-I-SceI-763bp-PvuII
S8P8S I-SceI-8bp-PvuII-8bp-I-SceI
The substrates P and S6P6S are also called unaddressed and addressed
substrates, respectively.
Table 1. Overview of the linkers used in the engineered PvuII-I-SceI
fusions
Linker name Length Sequence Source
LH 10 AA GSHHHHHHGT Engineered
L6 6 AA ASRTTG Engineered
LN 10 AA ASGGSGSGSG Engineered
L+ 10 AA ASTKQLVKSG FokI
L  10 AA ASGDSGSDSG Engineered
Nucleic AcidsResearch, 2012, Vol.40,No. 2 851ruled out, therefore, that the protein exists as a monomer
in solution, since it sediments faster than a sphere of the
corresponding mass. For the dimer a frictional ratio of
f/f0=1.58 can be calculated from the sedimentation coef-
ﬁcient. As hydrated spherical proteins are expected to
yield frictional ratios in the range of 1.1–1.2 (49), the
shape of PL6S* must deviate substantially from a
sphere, suggesting that it is an elongated homodimer
and/or contains ﬂexible regions that increase the frictional
coefﬁcient of the protein. Under low salt conditions the
sedimentation coefﬁcient increased slightly to s20,w=4.6 S
(Figure 4), and a molar mass of about 80kg/mol was
obtained from the c(s) analysis. This indicates that the
PL6S* homodimer formed under low salt conditions is
slightly more compact than under high salt conditions.
Identiﬁcation of residues in PvuII that increase the
speciﬁcity of the fusion enzyme
The fusion enzymes PL6S* and PL+S* are still able to
cleave unaddressed PvuII-sites (Figure 3A), albeit with
much lower rate than the addressed sites. There are in
principle two possibilities to increase the preference of
the fusion enzymes for the addressed site, which both
rely on making the cleavage activity of the cleavage
module PvuII dependent on the binding of the additional
binding modules I-SceI* to the I-SceI site: (i) either by
decreasing the activity (kcat, Km) of PvuII so that it
cannot cleave DNA if not positioned by I-SceI*, or (ii)
by weakening the dimer interface of PvuII to make a
proper subunit–subunit interaction, which is a prerequisite
for DNA cleavage, dependent on binding of the I-SceI*
modules to their target sites.
For the ﬁrst approach (i) the mutations T46G, known
to be responsible for high ﬁdelity (Zhenyu Zhu, New
England Biolabs, personal communication) and Y94F,
known to have a decreased Mg
2+ binding ability (50)
were introduced into PvuII (Figure 5, right panel) and in
the fusion enzyme. Indeed the PvuII(T46G,Y94F) variant
showed an  100-fold decrease in activity compared to
wtPvuII (data not shown). To weaken the PvuII dimer
interface (ii) without affecting the catalytic activity too
much we decided to choose residues in the N-terminal
a-helices (Figure 5, left panel) which form close contacts
between the two subunits and are far away from the active
center (Figure 5, lower panel). The residues L12 and H15
were substituted by Glu and Asp, respectively, and
Figure 3. Cleavage activity of fusion enzymes with different linkers on linearized DNA. The DNA substrate contains either (A) a single PvuII site
(light gray bar) or (B) the tripartite recognition site consisting of a PvuII site (light gray bar) ﬂanked by two I-SceI sites (dark gray bars) each 6bp
away, and an additional unaddressed PvuII site. The experiment was performed under optimized conditions for the corresponding enzymes, namely
Buffer Green for PvuII and optimized KGB for the fusion enzymes. The products of addressed cleavage at the tripartite recognition site are indicated
by arrows and the products of unaddressed cleavage at PvuII sites by asterisks. The percentage of unaddressed cleavage is shown at the bottom.
Figure 4. Sedimentation coefﬁcient distributions in an analytical ultra-
centrifugation experiment with PL6S* at different salt concentrations.
PL6S* at concentrations of 3.3 or 3.5mM was analyzed in sedimenta-
tion velocity experiments at 500mM NaCl (solid line) or 100mM NaCl
(dashed line), respectively. c(s) analysis using the program SEDFIT
yielded a single sedimenting species with s20,W=4.4 S under high salt
and s20,W=4.6 S under low salt conditions, indicating that PL6S* is a
stable homodimer. The purity and stability of the protein analyzed had
been determined before by SDS-PAGE of 1.7mg protein diluted in
either low or high salt buffer (see insert). The theoretical molecular
weight of one subunit of PL6S* is 46.7kDa.
852 Nucleic Acids Research, 2012,Vol. 40,No. 2thereby generate electrostatic repulsion between the two
subunits. Furthermore the central residue of this helix P14
was substituted by Gly in order to affect the bending of
the helix and by this reduce the interface contacts. These
variants were introduced individually into wtPvuII and in
the fusion enzyme as well. The PvuII(L12E), PvuII(P14G)
and PvuII(H15D) variants were characterized with respect
to their kinetic parameters, which showed, that the muta-
tions had only a slight inﬂuence on the catalytic activity
(Supplementary Table S1).
Characterization of fusion enzymes containing different
amino acid substitutions in the cleavage module PvuII
We tested the effects of the amino acid substitutions T46G
and Y94F in the fusion enzymes containing the L6 or the
L+ linker by competition experiments with two internally
labeled PCR fragments containing either the addressed
site (S6P6S) or the unaddressed site (P) in equimolar con-
centration of enzyme and the two substrates (cPL6/+S* :
cS6P6S:c P=1:1:1) over 3h. The fusion enzymes PL6S*
(Figure 6A) and PL+S* (Figure 6C) containing wtPvuII
as cleavage module cleave the addressed site by factors
of  300 and 100 faster than the unaddressed site, respect-
ively (Figure 6E and Table 4). Consistent with our ﬁnding
that the PvuII(T46G, Y94F) variant has a highly re-
duced catalytic activity compared to wtPvuII, the variants
P(T46G, Y94F)L6S* (Figure 6B) and P(T46G,
Y94F)L+S* (Figure 6D) also have a much lower activity.
However, they show only a 10–20-fold faster addressed
than unaddressed cleavage rate (Figure 6E and Table 4).
Since I-SceI is the part of the fusion enzymes which
should be mainly responsible for speciﬁc DNA binding,
we wanted to investigate, whether the afﬁnity of the fusion
enzymes to the tripartite recognition site (S6P6S) is higher
than the afﬁnity for a ‘stand-alone’ I-SceI recognition site
(S) and is similar to the reported KD of 9.7nM for I-SceI
(51). For this purpose internally radiolabeled PCR frag-
ments containing either the sites S6P6S or S were used for
gel shift experiments under non-cleavage conditions. The
afﬁnity of the fusion enzymes for the S6P6S site was
slightly lower than the afﬁnity of I-SceI for its recognition
site. A ‘stand-alone’ I-SceI site (S), however, is bound by
the fusion enzyme with considerably lower afﬁnity than
the tripartite site (S6P6S) (Table 3). This indicates that
PvuII is likely to contribute to the binding ability of the
fusion enzyme to its speciﬁc site but disturbs the binding
of I-SceI to a ‘stand-alone’ I-SceI site.
Optimizing the spacer length within the tripartite target
sites with different distances between the PvuII and I-SceI
sites
Before testing the PvuII variants with a proposed weak-
ened dimer interface in the fusion constructs, we wanted to
ﬁnd out which linker is the preferred one in PvuII-I-SceI*
fusion proteins for cleaving substrates with different dis-
tances between the PvuII site and the I-SceI site. For this,
the linker variants PLHS*, PL6S*, PLNS*, PL+S* or
PL-S* were assayed for cleavage activity on plasmid
DNA substrates containing the target sites S4P4S,
S6P6S, S6x6S or S8P8S (Table 2 and Figure 7). All
variants cleave the addressed substrate with the 6bp dis-
tance between I-SceI and PvuII site (Figure 7B) with nearly
the same efﬁciency; in contrast, the substrate, which does
not contain a PvuII target site (S6 6S) between the I-SceI
sites, is not cleaved by any of the variants (Figure 7C). For
the substrates with a decreased (S4P4S, Figure 7A) or
increased (S8P8S, Figure 7D) distance between the
I-SceI and PvuII sites differences in the cleavage efﬁciency
were observed for the linker variants. The variants con-
taining a charged linker (PL+S* or PL-S*) have a prefer-
ence for the S4P4S substrate, PLHS* and PLNS* cleave the
substrates with the following preference: S6P6S>S8P8S>
S4P4S. PL6S* shows the preference predicted from the
model (Figure 1B): S4P4S<S6P6S>S8P8S. For this rea-
son the amino acid substitutions L12E, P14G and H15D
were introduced only into PL6S*.
Comparative analysis of the activity of PvuII-I-SceI
fusion proteins in DNA cleavage assays
The speciﬁcity of these variants was tested and as expected
from the kinetic parameters for PvuII(L12E), PvuII(P14G)
and PvuII(H15D) (Supplementary Figure S1), P(L12E)L6S*
(Figure 8A), P(P14G)L6S* (Figure 8B) and P(H15D)L6S*
(Figure 8C) show a higher speciﬁc activity compared to
P(T46G,Y94F)L6S* and P(T46G, Y94F)L+S* resulting
in>1000-fold faster addressed than unaddressed cleavage
rate (Table 4). This preference is seen even at 10 times
higher concentration of enzyme over the addressed and
the unaddressed substrate (Supplementary Figure S2). It
needs to be mentioned, however, that PL6S*,
P(L12E)L6S*, P(P14G)L6S* and P(H15D)L6S* also attack
substrates containing the dipartite site S6P, although
much more slowly than the tripartite site S6P6S
(Supplementary Figure S4). The preference for addressed
Figure 5. Structural details of PvuII (pdb 1pvi). The catalytic centre
composed of the residues D58, E68 and K70 is highlighted in green.
The positions of substitutions introduced into PvuII are: T46G (yellow)
increases the ﬁdelity of PvuII; Y94F (yellow) has a reduced Mg
2+
binding ability (50); L12E, P14G and H15D (red) are likely to
weaken the dimer interface.
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dressed cleavage could be detected, even after overnight
incubation (data not shown), which makes these fusion
proteins highly speciﬁc for the addressed substrate.
We determined also the binding afﬁnity of these variants
for the S6P6S substrates. The KD-values obtained for
P(L12E)L6S*, P(P14G)L6S* and P(H15D)L6S* were of
the same magnitude as the KD of I-SceI (Table 5). On a
substrate containing only an I-SceI site no speciﬁc binding
could be detected (Supplementary Figure S3).
Since off-site target cleavage is a common problem
of engineered nucleases of extended speciﬁcity (ZFN,
meganucleases, etc.), we wanted to test to what extent our
Figure 6. Competition cleavage experiments with fusion enzyme variants. The internally
32P labeled DNA fragments contain either the tripartite
recognition sequence S6P6S (a) or a single PvuII site (u), at equimolar concentrations of 10nM of both substrates. The two substrates were incubated
with (A)P L 6S*, (B) P(T46G, Y94F)L6S*, (C)P L +S* and (D) P(T46G,Y94F)L+S* for 3h at 37 C; after deﬁned time intervals samples were
withdrawn from the reaction mixture and analyzed by gel electrophoresis. The cleavage product obtained by cleavage at the addressed tripartite
recognition site is indicated by an arrow and the position of the expected cleavage product obtained by cleavage at the unaddressed PvuII site by an
asterisk. (E) The autoradiograms (A–D) were quantiﬁed and the percentage of cleavage was plotted against time. Filled symbols show the addressed
cleavage and open ones the unaddressed cleavage.
Table 3. Summary of the binding constants KD determined for
PL6S*, P(T46G,Y94F)L6S*, PL+S* and P(T46G,Y94F)L+S* on DNA
substrates containing the tripartite site (S6P6S) or a single I-SceI site
(S)
Enzyme Substrate KD (nM)
PL6S* S6P6S 31±3
S 144±20
P(T46G,Y94F)L6S* S6P6S 31±2
S 119±16
PL+S* S6P6S 18±1
S 212±29
P(T46G,Y94F)L+S* S6P6S 31±3
S >250
854 Nucleic Acids Research, 2012,Vol. 40,No. 2engineered fusion enzymes would cleave high molecular
DNA at unwanted sites. For our fusion proteins PLxS*
the most critical unwanted cleavage would be unaddressed
cleavage i.e. cleavage at PvuII sites not addressed by I-SceI
sites. For this purpose we used bacteriophage  -DNA,
which contains 15 PvuII sites, in a cleavage experiment
(Figure 9). All variants produced, namely the different
linker variants, the T46G, Y94F variants of PvuII alone
or in the fusion enzyme context and the variants L12E,
P14G and H15D also of PvuII alone or in the
fusion enzyme context were used in a 1:1 ratio of
enzyme over PvuII sites to see, if genomic DNA is a
target for the meganuclease. The variants that we
prepared at the beginning of our study (PLHS*, PL6S*,
PLNS*, PL+S*, PL S*) show cleavage of  -DNA, even
though not as complete as observed with wtPvuII. The
variants with a decreased catalytic activity
[P(T46G,Y94F)L6S*, P(T46G,Y94F)L+S]* show no
cleavage of  -DNA, but since PvuII(T46G,Y94F) also
shows reduced cleavage activity compared to wtPvuII,
the speciﬁc effect (i.e. absence of cleavage) is not as high
as for P(L12E)L6S* and P(P14G)L6S* which also do not
cleave  -DNA, whereas PvuII(L12E) and PvuII(P14G) do
so. Surprisingly, P(H15D)L6S* shows some cleavage,
although it did not cleave the unaddressed substrate in
the competition experiment (Figure 8C). We have
veriﬁed the speciﬁcity of some of our fusion constructs
also in vivo by demonstrating that E. coli cells producing
fusion proteins are viable even in the absence of PvuII
methyltransferase.
We were able to show that the variants P(L12E)L6S*
and P(P14G)L6S* do not cleave PvuII sites on high mo-
lecular weight DNA and wanted to see ﬁnally, if these
fusion enzymes have a preference for a certain distance
between the I-SceI and PvuII sites. For this purpose,
plasmid DNA containing either the S4P4S, S6P6S or
S8P8S target was tested for cleavage by P(L12E)L6S*,
P(P14G)L6S* and P(H15D)L6S*. The amount of linear
DNA produced was determined by densitometry and the
mean of three experiments was plotted (Figure 10). All
enzymes cleave S6P6S preferentially, but to different
degrees. Whereas P(L12E)L6S* has an  2-fold preference
for S6P6S over S4P4s and S8P8S, and P(H15D)L6S* a 1.5-
and 2-fold preference over S4P4S and S8P8S, respectively,
P(P14G)L6S* shows a 8–10-fold preference for S6P6S
over the other substrates. Taking all the results obtained
together, P(P14G)L6S* is the fusion enzyme of choice,
which cleaves highly preferentially the addressed substrate
in the presence of unaddressed substrate, does not cleave
unaddressed PvuII sites in  -DNA and has a speciﬁcity for
substrate with two I-SceI sites and a PvuII site in the
middle separated by 6bp on each site. These properties
make this enzyme a suitable candidate to be tested for
gene targeting in further in vivo experiments.
DISCUSSION
Nucleases that are speciﬁc enough to recognize and cleave
only unique DNA sequences in complex genomes are
needed for the purpose of introducing new genetic material
into complex genomes by homologous recombination. In
gene targeting, new DNA sequences (e.g. complete genes)
are introduced by making a speciﬁc double-strand cut at
the locus of interest, which is repaired by recombination
with the new DNA supplied in trans. There are two
options to achieve this: (i) to use a nuclease that recognizes
a sequence that had been speciﬁcally introduced into the
genome at the locus of interest in a previous genome en-
gineering experiment, or (ii) to reprogram a speciﬁc nucle-
ase, or to program a non-speciﬁc nuclease to recognize a
Figure 7. DNA cleavage experiments with all linker variants and the
different substrates at equimolar concentrations (8nM). (A) S4P4S,
(B) S6P6S, (C) S6x6S and (D) S8P8S were incubated with PvuII,
PLHS*, PL6S*, PLNS*, PL+S* and PL-S*, respectively, for 3h under
optimized conditions (see main text).
Nucleic AcidsResearch, 2012, Vol.40,No. 2 855certain sequence at the locus of interest. We have pursued
here the ﬁrst option, namely to produce a nuclease with a
unique speciﬁcity that could be used in particular for
introducing new genes into genomes, in which recognition
sequences for highly speciﬁc nucleases are already present
or had been introduced for future targeted genome opti-
mization as it has been done for example in agronomic
crops (52,53).
Nucleases with extended speciﬁcity so far have been
produced mainly by engineering homing endonucleases
(‘meganucleases’) or by fusing a non-speciﬁc nuclease, typ-
ically the DNA cleavage domain of the FokI restriction
endonuclease and three to four zinc ﬁngers (!ZFN). In
the new approach described here, we utilize the same
architecture as utilized for ZFNs, triple helix forming
oligonucleotide-linked nucleases, or TALENs, in which a
DNA-binding module is fused to a DNA-cleavage module
to generate an enzyme, whose distinct properties can be
exploited to target a unique sequence in complex genomes.
The binding module of choice for our purpose is derived
from an inactive (denoted by *) variant of the monomeric
homing endonuclease I-SceI (I-Sce*) that speciﬁcally rec-
ognizes an 18-bp sequence, but because of amino acid
substitutions in the active site (Asp44!Ser or Asn;
Asp145!Ala) is only competent in speciﬁc DNA
binding but not in cleavage [cf. (20)]. In addition,
I-SceI* lacks the nine C-terminal amino acid residues,
which are not resolved in the co-crystal structure (40).
For the DNA-cleavage module, we employ variants of
the homodimeric type II restriction endonuclease PvuII.
Different from the non-speciﬁc cleavage domain of FokI
in the ZFNs, PvuII in our fusion proteins not only
supplies the catalytic function, but also, in principle,
could increase the overall speciﬁcity. Our PvuII-I-SceI*
fusion proteins are homodimers (as shown by analytical
ultracentrifugation), consisting of the central PvuII
homodimer, whose subunits are fused at their C-termini
to the N-termini of I-SceI*, which carries a C-terminal
Strep-tag (Figure 1A). They bind the tripartite recognition
site, consisting of a central PvuII recognition site and two
ﬂanking I-SceI recognition sites with higher afﬁnity than a
‘stand-alone’ I-SceI recognition site.
A critical issue for the usefulness of engineered nucle-
ases with extended speciﬁcity, in general, is that cleavage
at so-called ‘off-target sites’ must be prevented (54). For
PvuII-I-SceI* fusion proteins it is mandatory that they do
not attack an unaddressed PvuII site (i.e. a PvuII site not
ﬂanked by I-SceI sites), and should prefer PvuII sites
ﬂanked on both sides with an I-SceI site over PvuII sites
ﬂanked on only one side with an I-SceI site, although we
do not regard cleavage at PvuII sites ﬂanked on only one
side with an I-SceI site as critical, given the length of the
Figure 8. Competition cleavage experiments with the fusion enzyme
variants containing amino acid substitutions in the dimer interface
and internally
32P labeled DNA fragments containing the addressed
tripartite recognition site (S6P6S) or the unaddressed PvuII site
alone (P). The experiment was performed as described in Figure 5.
Figure 8. Continued
The autoradiogram is shown in the insert, the result of the quantiﬁca-
tion is shown as a reaction progress curve (percent cleavage vs. time):
(A) P(L12E)L6S*, (B) P(P14G)L6S* and (C) P(H15D)L6S*. The arrow
indicates the cleavage product obtained by addressed cleavage (closed
circle) and the asterisk the position of the expected cleavage product of
unaddressed cleavage (open circle).
856 Nucleic Acids Research, 2012,Vol. 40,No. 2combined recognition sequences of I-SceI and PvuII. We
have employed a 2-fold strategy to achieve the required
speciﬁcity of our fusion protein using either different
linkers or introducing different amino acid substitutions
into PvuII.
In a preliminary experiment, we had linked a catalytic-
ally inactive version of I-SceI via its N-terminus to the
C-terminus of the single chain version of His6-tagged
PvuII (scPvuII), in order to conﬁrm that such a construct
would not attack a DNA with one I-SceI site and without
a PvuII site. To our surprise it turned out that the DNA
was cleaved. Sequencing of the product identiﬁed the site
of cleavage as a PvuII ‘star’ site (CAGCAG), which differs
from a canonical PvuII site (CAGCTG) by a single base
pair. Furthermore, at low Mg
2+ (‘physiological’) concen-
trations the PvuII-I-SceI* fusion protein cleaves a plasmid
DNA containing a composite site consisting of an I-SceI
site and a PvuII site 8bp downstream much better than
scPvuII. These results showed that the scPvuII-I-SceI*
fusion protein is functional and that I-SceI* can direct
PvuII to a site that is related to a PvuII site. This result
prompted us to pursue our experiments with fusion
proteins consisting of wtPvuII and I-SceI*.
We had generated a structural model for PvuII-I-SceI*
(Figure 1B). It suggested that the fusion protein designed
to cleave a quasi-palindromic site consisting of a PvuII site
ﬂanked at a distance of  6bp by two I-SceI sites oriented
in opposite directions could be engineered with two linkers
between the N-terminus of I-SceI* and the C-terminus of
PvuII,  6–10 amino acid residues in length. This fusion
protein would approach the DNA from one side. Of
course, the distance of the PvuII and I-SceI sites and the
linker length and its amino acid composition needed to be
optimized. It turned out that a 6bp distance and a linker
of 6 amino acids (ASRTTG) proved to be optimal. A
ﬂexible 10 amino acid linker (ASTKQLVKSG) was also
acceptable.
Since PvuII-I-SceI* fusion proteins even with optimized
linkers were not absolutely speciﬁc for the addressed site,
we introduced amino acid substitutions into PvuII that are
known to affect Km and kcat. The intention was to in-
crease the contribution of I-SceI* to speciﬁcity relative
to PvuII, both in the ground (Km) and in the transition
state (kcat). It is interesting to note that slowing down ca-
talysis by introducing the T46G and Y94F amino acid
substitutions into PL6S* and PL+S* results in a decrease
of speciﬁcity [compare for example PL6S* 338 with
Figure 10. Evaluation of DNA cleavage assays with three different
plasmid substrates containing the sites S4P4S (light gray), S6P6S
(gray) and S8P8S (dark gray). The variants P(L12E)L6S*,
P(P14G)L6S* and P(H15D)L6S* were tested for cleavage of these sub-
strates in equimolar concentrations of DNA and protein for 3h at 37 C
under optimized conditions. The amount of linear DNA was estimated
by densitometry of the ethidium bromide stained agarose gel and the
mean and standard deviation were calculated and plotted (n=3).
Figure 9. DNA cleavage experiments with all fusion enzymes and all
PvuII variants and bacteriophage  -DNA, which harbors 15 PvuII
sites. DNA and enzyme concentrations were chosen such, that the
molar ratio between enzyme and PvuII sites is 1:1.
Table 4. Summary of activities on addressed and unaddressed
substrates and resulting speciﬁcities determined by competition
cleavage experiments
a for all tested fusion enzyme variants
Enzyme Activity (nMmin
 1) Speciﬁcity
Addressed Unaddressed (Addressed/
unaddressed)
PL6S* 0.88±0.07 0.0026±0.0004 338
PL+S* 1.00±0.08 0.014±0.004 72
P(T46G, Y94F)L6S* 0.018±0.005 0.0010±0.0004 18
P(T46G, Y94F)L+S* 0.025±0.009 0.0023±0.0008 11
P(L12E)L6S* 0.39±0.05 <0.0001
b >1000
P(P14G)L6S* 0.47±0.02 <0.0001
b >1000
P(H15D)L6S* 0.44±0.06 <0.0001
b >1000
acarried out in triplicate.
bbelow detection limit.
Table 5. Summary of the binding constants determined for
P(L12E)L6S*, P(P14G)L6S* and P(H15D)L6S* on DNA substrates
containing the tripartite site (S6P6S)
Enzyme Substrate KD (nM)
P(L12E)L6S* S6P6S 9±1
P(P14G)L6S* S6P6S 9±1
P(H15D)L6S* S6P6S 2.3±0.4
Nucleic AcidsResearch, 2012, Vol.40,No. 2 857P(T46G,Y94F)L6S*  18]. This can be explained by an
‘allosteric coupling’ between the binding and the cleavage
module in our fusion enzymes. A consequence of this
coupling could be that the effect of reduced cleavage
activity by the substitutions T46G and Y94F is only
seen on the addressed site where PvuII is positioned cor-
rectly by the I-SceI mojety. On the unaddressed site this
effect is not seen because the fusion enzyme is not able to
bind in a catalytically productive manner. This is
illustrated for example by our ﬁnding that PL6S* does
not bind to an isolated PvuII site.
Since proper juxtaposition of the two subunits of PvuII
is essential for double-strand cleavage we ﬁgured that
interference with the subunit/subunit interface might
affect PvuII activity but not that of the fusion protein,
which is kept in a catalytically proﬁcient dimer state by
I-SceI* binding to its recognition sites. Although amino
acid substitutions in the subunit/subunit interface did not
abolish the DNA cleavage activity of PvuII, indicating
that PvuII remains dimeric, they increased the speciﬁcity
of the PvuII-I-SceI* fusion protein so much that no un-
addressed DNA cleavage could be observed anymore.
Presumably, the amino acid substitutions in the PvuII
dimer interface impair DNA access for the catalytic
center of PvuII in the fusion enzyme if the I-SceI/DNA
interaction does not take place and thereby cannot
support productive dimer formation of PvuII on the
DNA.
In summary, given the detection limit of our DNA
cleavage experiments, the preference of our best PvuII-I-
SceI* fusion proteins is better than 1000 for an addressed
site over an unaddressed site.
CONCLUSIONS
We have produced a fusion protein consisting of a
LAGLIDADG homing endonuclease and a type IIP re-
striction enzyme for highly speciﬁc DNA cleavage as it is
required for gene targeting. Nucleases with extended spe-
ciﬁcity that contain a DNA binding module fused to a
DNA cleavage module invariably make use of the
non-speciﬁc DNA cleavage domain of the type IIS restric-
tion endonuclease FokI, as exempliﬁed by the zinc ﬁnger
nucleases. They have the advantage of being program-
mable by choosing appropriate zinc ﬁngers to recognize
series of trinucleotide sequences. The ZFN concept has
been very successful, in particular after amino acid substi-
tutions were introduced into the subunit-subunit interface
in order to prevent homodimerization (55,56). Still, the
problem of off-site cleavage, although very much
reduced, still exists, as was systematically analyzed in
two very recent studies (57,58).
We have wondered, whether other DNA cleavage mod-
ules could be used instead of the non-speciﬁc DNA
cleavage domain of FokI to widen the repertoire of
modules to be combined in engineering chimeric nucle-
ases. In principle, also a speciﬁc DNA-cleavage module,
for example a type IIP restriction endonuclease, could be
used, as long as one can make DNA cleavage absolutely
dependent on the binding of the DNA binding module.
In this case one could take advantage of the speciﬁcity
mediated by the cleavage module in addition to the
DNA recognition by the DNA binding module. Our
study shows that this is possible, as demonstrated for
the tripartite site comprising the recognition sequences
of the I-SceI homing endonuclease and the PvuII restric-
tion endonuclease. To achieve the needed extraordinary
speciﬁcity it is necessary to optimize the DNA binding
module, the linker and the DNA cleavage module.
Presumably, every fusion construct must be optimized in-
dividually. Our fusion enzyme is not freely programmable.
However, for gene targeting purposes, one may introduce
extended recognition sequences sites in the genome of
interest at a so called ‘safe harbor’ locus, which can then
be used reliably for genome engineering.
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